首頁 › 小細胞肺癌 › 紐約州 › New York City
New York City, NY 的 小細胞肺癌 臨床試驗
22 項針對 小細胞肺癌 的研究正在 New York City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
招募中2 期
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center, New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, New York
A Study of Armored CAR T Cells in People With Cancer
招募中1 期
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- Cornell University - NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
招募中1/2 期
- Memorial Sloan Kettering, New York
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
招募中1/2 期
- Memorial Sloan Kettering Cancer Center (MSKCC), New York
- Icahn School of Medicine at Mount Sinai PRIME, New York
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
招募中1 期
- NYU Langone Health, New York
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
招募中1 期
- New York University Cancer Institute, New York
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
招募中1/2 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
招募中1 期
- Memorial Sloan Kettering Cancer Center, New York
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
招募中3 期
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island, New York
- New York University Cancer Center - Laura and Isaac, New York
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
招募中1/2 期
- Columbia University Medical Center - Herbert Irving Pavilion, New York
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- Columbia University, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Hospital-at-Home for People Receiving Tarlatamab
招募中
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
招募中2 期
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Lung Cancer Biomarkers and Screening
招募中觀察性研究歡迎健康志工
- NYU Cancer Institute at New York University Medical Center, New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
招募中1/2 期
- Weill Cornell Medicine, Cornell University (site 126), New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 107, New York
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
招募中觀察性研究
- Icahn School of Medicine at Mount Sinai, New York
其他城市的 小細胞肺癌 試驗
- Houston, TX26 項研究
- Arlington, VA23 項研究
- Boston, MA21 項研究
- Los Angeles, CA20 項研究
- Nashville, TN20 項研究
- Orlando, FL15 項研究
- Dallas, TX13 項研究
- Cleveland, OH13 項研究
- Chicago, IL13 項研究
- St. Louis, MO13 項研究
- Detroit, MI12 項研究
- Washington, DC12 項研究
New York City 的其他研究
- 乳癌136 項研究
- 非小細胞肺癌121 項研究
- 癌症（所有類型）109 項研究
- 前列腺癌103 項研究
- 轉移性癌症93 項研究
- 大腸直腸癌78 項研究
- 卵巢癌69 項研究
- 肺癌60 項研究
- 多發性骨髓瘤60 項研究
- 胰臟癌60 項研究
- 子宮內膜癌52 項研究
- 急性髓系白血病51 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。